170877 ⎘
Detection or diagnosis of diseases; Genitourinary disorders Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
METHODS AND COMPOSITIONS FOR DIAGNOSIS OF UROSEPSIS AND URINARY TRACT INFECTION
#602Detection of HIV-related proteins in urine
#603Systems and methods for characterizing kidney diseases
#604Detection of HIV-related proteins in urine
#605Acute kidney injury risk testing
#606Tmsb4 as a Biomarker for IgA Nephropathy
#607Compositions and methods for treating renal disease
#608NOVEL ROLE OF ALPHA-GALACTOSIDASE ACTIVITY AS A BIOMARKER IN KIDNEY DISEASE
#609Human renal disease marker substance
#610Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#611METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#612Method of calculating a phosphorus-protein ratio
#613METHOD FOR TEST ON DIABETIC NEPHROPATHY
#614TEST METHOD ON RENAL DISEASES
#615METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#616Type IV collagen-like immunoreactive peptide
#617URINARY GM2 ACTIVATOR PROTEIN AS A MARKER OF ACUTE RENAL FAILURE OR THE RISK OF DEVELOPING ACUTE RENAL FAILURE
#618NEW BIOMARKERS FOR ASSESSING KIDNEY DISEASES
#619APOLIPOPROTEIN L- I VARIANTS AND THEIR USE
#620METHOD FOR ASSESSING ARTERIOSCLEROSIS AND DIABETIC NEPHROPATHY
#621Method And Markers For Diagnosing Acute Renal Failure
#622Methods for Predicting Cardiovascular Mortality Risk
#623METHODS OF PROGNOSIS IN CHRONIC KIDNEY DISEASE
#624Methods and composition for measuring the amount of Vitamin D derivatives
#625Anti-CD27 humanized monoclonal antibody
#626METHOD OF DIAGNOSING RENAL DISORDERS
#627USE OF URINARY NGAL TO DIAGNOSE AND MONITOR HIV-ASSOCIATED NEPHROPATHY (HIVAN)
#628Biomarkers of renal injury
#629Markers of renal transplant rejection and renal damage
#630Use of megalin in urine as marker for detecting renal disorder
#631METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#632METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#633Biomarkers for the Diagnosis of Renal Allograft and Kidney Status
#634Signal biomarkers
#635Method for detecting renal disease comprising measuring human megalin in urine
#636METHOD AND MARKER FOR DIAGNOSIS OF TUBULAR KIDNEY DAMAGE AND ILLNESSES
#637Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#638PREDICTION OF NON-FATAL AND FATAL ATHEROTHROMBOTIC EVENTS
#639Method for detecting presumed IgA nephropathy and method for screening IgA nephropathy patients
#640Method of treating renal dysfunction based on perlecan as a biomarker
#641METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#642METHODS FOR DIAGNOSING KIDNEY DAMAGE ASSOCIATED WITH HEART FAILURE
#643DOSING AND MONITORING PATIENTS ON NITROGEN-SCAVENGING DRUGS
#644Naphthalene-based inhibitors of anti-apoptotic proteins
#645Devices and Methods for Enrichment and Alteration of Circulating Tumor Cells and Other Particles
#646NOVEL USES OF VEGFXXXB
#647DIFFERENTIATING CARDIAC- AND DIABETES MELLITUS-BASED CAUSES OF KIDNEY DAMAGE
#648Peptide biomarkers predictive of renal function decline and kidney disease
#649Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
#650Prognostic biomarkers for the progression of primary chronic kidney disease
#651EVALUATING RENAL FUNCTION
#652Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease
#653Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#654Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#655Anti-αβantibodies and uses thereof
#656Methods of Treatment
#657Autosomal-Dominant Polycystic Kidney Disease (ADPKD)
#658URINARY BIOMARKERS FOR SENSITIVE AND SPECIFIC DETECTION OF ACUTE KIDNEY INJURY IN HUMANS
#659Methods, devices and kits for detecting or monitoring acute kidney injury
#660Methods of diagnosing and predicting renal disease
#661Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
#662COMBINED NATRIURETIC PEPTIDE ASSAYS
#663Modified Thromboxane A2 Receptor Promoter Sequence
#664Methods of Using SDF-1 (CXCL12) as a Diagnostic and Mesenchymal Stem Cell (Multipotent Stromal Cell)-Specific Therapeutic Biomarker for the Treatment of Kidney Injury and Other Major Organs
#665Apparatus and methods for diagnosing renal disorders
#666METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#667LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#668Method for diagnosing immunoglobulin A nephropathy and TGBM nephropathy
#669SYSTEMS AND METHODS FOR CHARACTERIZING LUPUS ERYTHEMATOSUS
#670Novel Regulators of the Innate Immune System
#671SENSOR DEVICE FOR DETECTING TARGET PARTICLES BY FRUSTRATED TOTAL INTERNAL REFLECTION
#672Transcutaneous organ function measurement
#673METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#674METHOD FOR DIAGNOSING POLYCYSTIC KIDNEY DISEASE
#675METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#676WNT1 AS A RENAL DAMAGE BIOMARKER
#677Healthy kidney biomarkers
#678Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#679METHODS AND COMPOSITIONS FOR DETECTING RECESSIVE FAMILIAL FSGS AND USES THEREOF
#680Method for measuring human megalin
#681Methods for diagnosing acute kidney injury or renal failure
#682DIAGNOSTIC METHODS AND KITS USING FIBROBLAST GROWTH FACTOR-23
#683Methods for achieving a protective ACE2 expression level to treat kidney disease and hypertension
#684Serpine2 as a biomarker for IgA nephropathy
#685Methods and Devices for Detecting Kidney Transplant Rejection
#686Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#687METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#688IgA Nephropathy Testing Method And Test Kit
#689DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#690METHOD FOR PREDICTING A NEED FOR RENAL REPLACEMENT THERAPY (RRT)
#691METHODS OF TREATING KIDNEY DISEASE
#692Fibrosuppressant Biotherapeutics
#693METHOD OF ASSESSING KIDNEY FUNCTION IN A HUMAN SUBJECT
#694RATIONAL DESIGN OF REGENERATIVE MEDICINE PRODUCTS
#695Disease Specific Diagnostic Aid
#696Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4
#697Cell division marker
#698BIOMARKER FOR THE ESTIMATION OF ACUTE RENAL DISORDER AND PROGNOSIS OF THE DISORDER, AND USE OF THE BIOMARKER
#699Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
#700MOLECULAR SIGNATURE FOR FIBROSIS AND ATROPHY
#701IgA nephropathy testing method and test kit
#702High molecular weight Ngal as a biomarker for chronic kidney disease
#703BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#704URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY
#705Biomarkers associated with nephropathy
#706BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#707Urine and serum biomarkers associated with diabetic nephropathy
#708Diagnosis and/or prognosis of renal dysfunction
#709CHEMICAL MODULATION OF ELECTRONIC AND MAGNETIC PROPERTIES OF GRAPHENE
#710Devices for Detecting Renal Disorders
#711Methods and Devices for Detecting Kidney Damage
#712Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#713Computer Methods and Devices for Detecting Kidney Damage
#714Methods and devices for detecting obstructive uropathy and associated disorders
#715Methods and Devices for Detecting Glomerulonephritis and Associated Disorders
#716Markers of acute kidney failure
#717L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy
#718METHOD FOR ESTIMATING RISK OF ACUTE KIDNEY INJURY
#719Methods useful for vitamin D deficiency and related disorders
#720METHOD OF DETECTING CALCIFYING NANOPARTICLES AND SUSCEPTIBILITY TO CALCIFYING NANOPARTICLE INFORMATION
#721METHOD AND MARKER FOR DIAGNOSIS OF TUBULAR KIDNEY DAMAGE AND ILLNESS
#722Turbidimetric immunoassay for assessing human Cystatin C
#723Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1
#724GDF-15 AS BIOMARKER IN TYPE 1 DIABETES
#725TRPC6 involved in glomerulonephritis
#726BIOMARKERS FOR THE PREDICTION OF RENAL INJURY
#727Compositions and methods for detecting juvenile renal dysplasia or calcium oxalate stones in dogs
#728DIAGNOSTIC USE OF INDIVIDUAL MOLECULAR FORMS OF A BIOMARKER
#729Methods and compositions for the treatment of proteinuric diseases
#730METHOD FOR IDENTIFYING A RENAL FIBROSIS PROCESS USE OF SNAIL- ACTIVITY-INHIBITING COMPOUNDS IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS, METHOD FOR IDENTIFYING SAID INHIBITING COMPOUNDS, SAID PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF
#731USE OF BNP-TYPE PEPTIDES FOR PREDICTING DIALYSIS NEED
#732Methods of Modulating Angiogenesis
#733Naphthalene-based inhibitors of anti-apoptotic proteins
#734ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure
#735NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
#736DETECTION OF CONTRAST MEDIUM-INDUCED NEPHROTOXICITY
#737DIAGNOSTIC SUPPORT APPARATUS FOR RENAL DISEASE AND COMPUTER PROGRAM PRODUCT
#738METHOD FOR THE DETECTION OF THE IN-VIVO ACTIVITY OF NEUROTRYPSIN, USE OF THE METHOD AND USE OF THE C-TERMINAL, 22-KDA FRAGMENT OF AGRIN AS BIOMARKER IN DIAGNOSIS AND MONITORING OF NEUROTRYPSIN-RELATED DISTURBANCES
#739DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#740USE OF URINARY NGAL TO DISTINGUISH KIDNEY DISEASE AND PREDICT MORTALITY IN SUBJECTS WITH CIRRHOSIS
#741METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#742Quantitative and qualitative analysis apparatus for measuring the body fluid
#743IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL
#744METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#745Diagnostic Test to Exclude Significant Renal Injury
#746PROCESS AND MARKERS FOR THE DIAGNOSIS OF KIDNEY DISEASES
#747BIOMARKERS ASSOCIATED WITH NEPHROPATHY
#748METHOD, DEVICE AND KIT FOR DETERMINING CONDITIONS RELATED TO A DYSFUNCTION OF THE RENAL PROXIMAL TUBULE
#749Urine and serum biomarkers associated with diabetic nephropathy
#750Diagnostic kit for detecting urinary protein of a cat after cauxin removal
#751Diagnosis and monitoring of renal failure using peptide biomarkers
#752PREDICTIVE DIAGNOSTICS FOR KIDNEY DISEASE
#753DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#754Netrin-1 as a biomarker of injury and disease
#755Use of hematopoietic growth factor inducible neurokinin-1 (HGFIN) as a biomarker for renal injury or renal disease
#756Anti-CD27 antibody
#757Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress
#758Hepcidins as biomarkers for impending lupus nephritis flare
#759Use of β-2-microglobulin to assess glomerular alterations and damage in the kidney
#760Method of selecting phosphate binder and its uses thereof
#761Renal monitor
#762METHODS FOR DETECTING AND TREATING KIDNEY DISEASE
#763BLOOD DIAGNOSIS METHOD FOR DIALYSIS PATIENT AND DIALYSIS MACHINE
#764Detection of HIV-related proteins in urine
#765Methods and compositions for diagnosis and prognosis of renal artery stenosis
#766Urinary biomarkers to predict long-term dialysis
#767Method for diagnosing kidney disease comprising detecting the level of annexin A2
#768ADIPONECTIN FOR THE TREATMENT AND DIAGNOSIS OF ALBUMINURIA
#769Turbidimetric immunoassay for assessing human Cystatin C
#770METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#771Diagnostic test for renal injury
#772Biomarkers for renal disease
#773METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#774PREDICTIVE BIOMARKERS FOR CHRONIC ALLOGRAFT NEPHROPATHY
#775METHODS, KITS, AND ANTIBODIES FOR QUANTITATIVE DETERMINATION OF PARATHYROID HORMONE MOLECULES WITH INTACT C-TERMINUS
#776DETECTION OF NGAL IN CHRONIC RENAL DISEASE
#777Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
#778Fluorescent water-soluable conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same
#779Methods of treatment using ammonia-scavenging drugs
#780LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS
#781Diagnostic Test to Exclude Significant Renal Injury
#782METHOD FOR MEASURING PROTEIN
#783Measurement of succinate in urine samples as a biomarker of kidney damage in diabetic subjects
#784Method for distinguishing between kidney dysfunctions
#785Diagnostic and therapeutic uses of gelsolin in renal failure
#786Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4
#787Method for the early identification and prediction of kidney injury
#788Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery
#789COMPOSITIONS AND METHODS FOR DETERMINING NEPHROTOXICITY
#790Acute renal injury
#791DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#792SYSTEMS AND METHODS FOR CHARACTERIZING KIDNEY DISEASE
#793Type IV collagen-like immunoreactive peptide
#794METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#795TISSUE REJECTION
#796Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal Disorders
#797METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#798IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL
#799METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#800Method for measuring human megalin
#801Methods of detecting early renal disease in animals
#802LXR ligand testing method
#803Method of Detecting Kidney Dysfunction
#804Peptide biomarkers predictive of renal function decline and kidney disease
#805Methods of treatment of renal disease
#806Use of the AXL receptor for diagnosis and treatment of renal disease
#807Method for screening therapeutic agent for glomerular disorder
#808Reagent and kit for early diagnosis of kidney disease
#809Anti-αβantibodies and uses thereof
#810Antibody Reactive Specifically to Age Derived from 3,4-Dge
#811Megsin/Rage/Inos-Overexpressing Renal Disease Model Animals and Methods for Evaluating Compounds Using the Model Animals
#812Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
#813Synapse-specific proteins in glomeruli
#814Systems And Methods For Characterizing Contrast Induced-Nephropathy
#815Methods for identifying modulators of tumor necrosis factor receptors
#816Method for Diagnosing Membranous Glomerulonephritis Disease and a Kit Thereof
#817Method for assessing arteriosclerosis and diabetic nephropathy
#818Markers of renal transplant rejection and renal damage
#819METHODS
#820PREDICTING DIABETIC NEPHROPATHY
#821DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#822Detection of Gadolinium Chelates
#823Compositions and methods for detecting and treating renal injury and inflammation
#824Methods, kits, and antibodies for detecting parathyroid hormone
#825Compositions and methods relating to polycystic kidney disease
#826Thermoelectric sensor for analytes in a fluid and related method
#827TRPC6 involved in glomerulonephritis
#828Methods for detecting and treating kidney disease
#829DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#830METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#831Methods of diagnosing colon adenocarcinoma using mRNA encoding the human g-protein coupled receptor, HGPRBMY23
#832Methods, kits, and antibodies for detecting parathyroid hormone
#833METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#834Systems and methods for characterizing kidney diseases
#835Method and kit for the early detection of impaired renal status
#836Method for examining kidney diseases
#837Diagnosis and treatment of human kidney diseases
#838Functional immunoassay
#839Cell division marker
#840Biomarkers for kidney diseases and method for using same
#841Predicting diabetic nephropathy
#842Methods for achieving a protective ACE2 expression level to treat kidney disease and hypertension
#843Transgenic mice carrying the HP-2 gene and uses as models for vascular diseases
#844Method for the Early Detection of Renal Disease Using Proteomics
#845Detection of NGAL in chronic renal disease
#846Devices and methods for enrichment and alteration of circulating tumor cells and other particles
#847Novel use of edg receptors
#848Method and markers for the diagnosis of renal diseases
#849Compositions and methods for treatment of chronic and infectious diseases
#850Anti-feline albumin antibodies
#851Vaccine compositions for prevention of chronic and infectious diseases
#852Diagnosis and treatment of Alzheimer disease
#853METHOD FOR REDUCING LYSOZYME ENZYMATIC ACTIVITY
#854TRPC6 involved in glomerulonephritis
#855Diagnosis of kidney damage and protection against same
#856Method of evaluating a subject for risk or predisposition of reduced renal function over time
#857Diagnosis and treatment of human kidney diseases
#858Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
#859Classifying and predicting glomerulosclerosis using a proteomics approach
#860Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
#861Method for assessing arteriosclerosis and diabetic nephropathy
#862Reagent sets and gene signatures for renal tubule injury
#863Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases
#864Calcium challenge test for detecting calcium homeostasis disorders
#865Compositions and methods for detecting pathogen infection
#866Reagent sets and gene signatures for renal tubule injury
#867Screening method
#868Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-1
#869Compositions and kits for detecting pathogen infection
#870Method for the early detection of renal injury
#871Test strip for creatinine determination
#872NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
#873Method of diagnosing nephrotic syndrome
#874Diagnosis and treatment of human kidney diseases
#875Diagnosis and treatment of human kidney diseases
#876Rat model of diabetic nephropathy
#877Systems and methods for characterizing kidney diseases
#878Secreted factors
#879Systems and methods for characterizing kidney diseases
#880Diagnosis and treatment of human kidney diseases
#881Methods of detecting biomarkers of endoplasmic reticulum (ER) stress-associated kidney diseases